Unexpectedly, the triple-negative (ER-, PR-, HER2-) breast cancer cell line MDA-MB-231, but not the hormone-sensitive breast cancer cells MCF7, exhibited high resistance to ac-LA. This evidence concerns the gene ERBB2 and breast carcinoma.